Cargando…

Combination effects of ellagic acid with erlotinib in a Ba/F3 cell line expressing EGFR H773_V774 insH mutation

BACKGROUND: Epidermal growth factor receptor H773_V774 insH (EGFR‐insH) is an EGFR exon 20 insertion mutation in non‐small cell lung cancer (NSCLC), which is naturally resistant to available EGFR tyrosine kinase inhibitors (TKIs) and lacks a patient‐derived cell line. METHODS: A Ba/F3 cell line expr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Chuanqi, Kong, Jindong, Miao, Fujun, Wang, Xuanjun, Sheng, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396384/ https://www.ncbi.nlm.nih.gov/pubmed/32525282 http://dx.doi.org/10.1111/1759-7714.13487

Ejemplares similares

Case Report: A good response to furmonertinib second-line treatment of an advanced lung adenocarcinoma patient with a rare EGFR exon 20 N771_P772insH mutation: A case report and literature review
por: Zhang, Xiao, et al.
Publicado: (2022)

Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
por: Townsley, C A, et al.
Publicado: (2006)

Long-lasting benefit on multimodal treatment combining osimertinib and stereotaxic radiotherapy for metastatic non-small cell lung cancer with the EGFR exon 20 insertion 773-774 HVdelinsLM: a case report
por: Louvet, Aurélie, et al.
Publicado: (2023)

A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non‐small‐cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase inhibitor
por: Chen, Lun‐Che, et al.
Publicado: (2019)

Construction of an interdigital-H linac at INS
por: Tomizawa, M, et al.
Publicado: (1994)

Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC
por: Bahce, Idris, et al.
Publicado: (2016)

Building 774: open for business
por: CERN Bulletin
Publicado: (2015)

Ribbon-cutting ceremony for Building 774
por: Corinne Pralavorio
Publicado: (2015)

Fundamental particles: Bat 774 at CERN
por: Soppelsa, Francesco, et al.
Publicado: (2016)

The elegant lines of the new Building 774
por: Anaïs Schaeffer
Publicado: (2012)

Ellagic acid Alleviates hepatic ischemia–reperfusion injury in C57 mice via the Caspase-1-GSDMD pathway
por: Wang, Hao, et al.
Publicado: (2022)

Return to Work Following Shoulder Surgery: An Analysis of 1,773 Cases
por: Jayasekara, Mudith, et al.
Publicado: (2020)

77.3 COVID-19 and Functional Neurological Disorders in Children and Adolescents
por: Frolov, Latoya
Publicado: (2022)

Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases
por: Estrozi, Bruna, et al.
Publicado: (2011)

773. Hypochlorous Acid Generating Electrochemical Catheter Prototype for Prevention of Intraluminal Infections
por: Flurin, Laure, et al.
Publicado: (2021)

773 Insurance Coverage Does Not Increase Risk of Depression and Anxiety in Burn Patients
por: Pezzopane, Laura, et al.
Publicado: (2022)

Antitumor effects of erlotinib in combination with berberine in A431 cells
por: Cuan, Xiangdan, et al.
Publicado: (2023)

Model measurement and present status of interdigital-H linac at INS
por: Tomizawa, M, et al.
Publicado: (1995)

Progress report of the interdigital-H linac for radioactive nuclei at INS
por: Tomizawa, M, et al.
Publicado: (1996)

In-Flight Alignment Using H (∞) Filter for Strapdown INS on Aircraft
por: Pei, Fu-Jun, et al.
Publicado: (2014)

Stochastic Integration H(∞) Filter for Rapid Transfer Alignment of INS
por: Zhou, Dapeng, et al.
Publicado: (2017)

Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset
por: Nishio, Kazuto, et al.
Publicado: (2021)

HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistant
por: Sueangoen, Natthaporn, et al.
Publicado: (2020)

773. Statins Decrease the Risk of Active Tuberculosis: A Propensity Score-Matched Analysis
por: Kim, Min-Chul, et al.
Publicado: (2018)

Ba(OH)(2) Equilibria in the System Ba-O-H-F, With Application to the Formation of Ba(2)YCu(3)O(6.5 + x) From BaF(2)-Precursors
por: Cook, L. P., et al.
Publicado: (2005)

Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutations
por: He, Qihua, et al.
Publicado: (2021)

Prevalence of diagnosis and direct treatment costs of back disorders in 644,773 children and youths in Germany
por: Ochsmann, Elke B, et al.
Publicado: (2010)

Pharmacogenomics characterization of the MDM2 inhibitor MI-773 reveals candidate tumours and predictive biomarkers
por: Vuaroqueaux, Vincent, et al.
Publicado: (2021)

773 Inhalation Injury Severity Score on Admission Predicts Overall Survival in Burn ICU Patients
por: Flinn, Ashley, et al.
Publicado: (2023)

Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain
por: Park, Jin H., et al.
Publicado: (2012)

Advanced lung adenocarcinoma in an EGFR-positive patient treated with Erlotinib for 52 months
por: Gonçalves, Ivone, et al.
Publicado: (2013)

Shikonin sensitizes wild-type EGFR NSCLC cells to erlotinib and gefitinib therapy
por: Li, Yang-Ling, et al.
Publicado: (2018)

Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer
por: Tang, Z, et al.
Publicado: (2008)

Impact of EGFR Mutation Detection Methods on the Efficacy of Erlotinib in Patients with Advanced EGFR-Wild Type Lung Adenocarcinoma
por: Tseng, Jeng-Sen, et al.
Publicado: (2014)

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomised controlled trials
por: Deng, Wusheng, et al.
Publicado: (2022)

774. Extrapulmonary Tuberculosis: Impact of Early Diagnosis and Treatment on Mortality
por: Walayat, Saqib, et al.
Publicado: (2018)

774. Sexual Behaviors and Attitudes of Intimate Partners of Ebola Survivors
por: Cunningham, Hannah M, et al.
Publicado: (2020)

Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation
por: Liu, Jing, et al.
Publicado: (2016)

Evaluation of the Free Radical Scavenging Activities of Ellagic Acid and Ellagic Acid Peracetate by EPR Spectrometry †
por: Kumar, Ajit, et al.
Publicado: (2021)

Thoracic trauma now and then: A 10 year experience from 16,773 severely injured patients
por: Horst, Klemens, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vf4j7ghb60vusvj2rnaoh8nako